ViroPharma Purchases Exclusive Option to Acquire Meritage Pharma - December 22, 2011
Meritage Pharma Reports Positive Phase 2b Data for Oral Budesonide Suspension in Pediatric Patients with Eosinophilic Esophagitis - May 10, 2011
Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients with Eosinophilic Esophagitis - January 22, 2009
Meritage Pharma, Inc. Announces Company Formation and $22.5 Million Series A Financing – June 16, 2008
